The urgent need to develop vaccines or therapeutics in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) has resulted in a significant increase in clinical trials worldwide. Many research institutes, healthcare organizations and biopharmaceutical companies worldwide are conducting clinical trials for COVID-19 vaccines and therapeutics. In the same way that CHRU has been involved in research to prevent and treat HIV, TB and HIV-associated cancers, we are committed to working with local and global partners to end COVID-19 as a global pandemic as a matter of urgency.

We are now part of the Covid-19 Prevention Trials Network and our first COVID-19 study is Janssen’s ESEMBLE study.

Current Studies